While not technically about the formation of nitrosamines within drug substances and products this may be of interest to those who have a manufacturing process that potentially exposes their product to atmospheric NOx (and ozonation).
Also - the levels of nitrosamines observed, in something like breathing, which you cannot avoid, put the levels set in drug products into perspective.
